Advertisement

Why Aurinia Pharmaceuticals Stock Is Flying Today

Why Aurinia Pharmaceuticals Stock Is Flying Today

Shares of Aurinia Pharmaceuticals (NASDAQ: AUPH), a mid-cap biotech company, closed trading Monday up by a healthy 26%. The stock raced higher in response to the FDA's approval of the company's oral lupus nephritis drug, Lupkynis (aka voclosporin). Lupkynis is indicated for patients with active lupus nephritis who are already receiving background immunosuppressive therapy.